pentoxifylline and kt 5720

pentoxifylline has been researched along with kt 5720 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carper, HT; Mandell, GL; Sullivan, GW	1

Other Studies

1 other study(ies) available for pentoxifylline and kt 5720

Article	Year
The specific type IV phosphodiesterase inhibitor rolipram combined with adenosine reduces tumor necrosis factor-alpha-primed neutrophil oxidative activity. International journal of immunopharmacology, 1995, Volume: 17, Issue:10 Topics: Adenosine; Carbazoles; Drug Synergism; Humans; In Vitro Techniques; Indoles; Neutrophils; Pentoxifylline; Phenethylamines; Phosphodiesterase Inhibitors; Pyrroles; Pyrrolidinones; Respiratory Burst; Rolipram; Superoxides; Tumor Necrosis Factor-alpha	1995

Article

Year

The specific type IV phosphodiesterase inhibitor rolipram combined with adenosine reduces tumor necrosis factor-alpha-primed neutrophil oxidative activity.

International journal of immunopharmacology, 1995, Volume: 17, Issue:10

Topics: Adenosine; Carbazoles; Drug Synergism; Humans; In Vitro Techniques; Indoles; Neutrophils; Pentoxifylline; Phenethylamines; Phosphodiesterase Inhibitors; Pyrroles; Pyrrolidinones; Respiratory Burst; Rolipram; Superoxides; Tumor Necrosis Factor-alpha

1995